Carl Zeiss Meditec AG (AFX.DE) XETRA

Currency In EUR

AD

Carl Zeiss Meditec AG

Address

Göschwitzer Straße 51-52

Jena, TH 07745

Germany

Phone

49 3641 2200

Sector

Healthcare

Industry

Medical - Specialties

Employees

5784

First IPO Date

March 22, 2000

Key Executives

NameTitlePayYear Born
Andreas PecherInterim Chairman of the Management Board & Interim CEO01971
Christian MunsterHead of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board41,0001971
Justus Felix WehmerChief Financial Officer & Member of the Management Board661,0001965
Eva-Maria HeineChief Human Resources Officer0N/A
Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical Technology0N/A
Steven C. SchallhornChief Medical Officer for Global Ophthalmic Devices0N/A
Euan S. ThomsonPresident of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit01963
Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.0N/A
Sebastian FrericksDirector of Investor Relations0N/A
Stefanie SpanagelChief Operating Officer0N/A
AD

Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.

AD